SA article aside...If your family member had this disease and the FDA approved it for only a 1-2 week label because they are not able to corroborate long term effectiveness, would you still buy the drug? I think the answer is still yes because of the unmet need. Now how much is the drug really worth to you? and thus the stock?
Canaccord raised Deckers estimates with a new $111 price target from 91 backing up Sterne Agee and Jeffries. NOW THE SQUEEZE will begin, AFTER tomorrows SHORT NUMBERS which are expected to be still high. MONDAY we should see this stock at $100.
Short attack.. Nothing in the company has changed except for every single analyst upgraded.
Anybody who parts with their shares is doing themselves a disservice. I did part with a few shares about a week ago, but guess what.. I add more!
Remember PT for 3 of these Analaysts is over $100!
OPTIONS EXPIRE TODAY! How much does anyone want to bet that we will close at 85!!???
Option monster on 11/26/2013:
"A big call spread topped yesterday's option activity in Deckers Outdoor as shares hit five-year highs.
optionMONSTER systems show that a trader bought 3,500 December 82.50 calls for $2.25, above the ask price, while selling 7,000 December 85 calls for $1.15. Previous open interest in the strikes were 33 and 66 contracts respectively, indicating that new positions were established.
This ratio spread takes in a credit of $0.05, which will be the profit if DECK remains below $82.50 through expiration in mid-December. The MAXIMUM gain would be realized with the stock right at $85 at that time. Above that level, the trader is effectively short shares."
Pay attention to the word MAXIMUM!
PURE manipulation to scare people